Singwu David Law, M.D.
NPI 1760709265ActiveIndividual· Internal Medicine, Critical Care Medicine· New York, NY
Internal Medicine, Critical Care Medicine (M.D.) in New York, New York, trained at New York Medical College (class of 2007). Their prescriptions cost Medicare Part D more than their services did: $4,767,623 for 12,059 claims, against $44,957 paid for services in 2024. Astrazeneca Pharmaceuticals LP was the largest of 11 companies reporting payments in 2025, $4,154 in all, mostly food and beverage.
Overview
| NPI | 1760709265 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | Yes |
| NPI issued | Apr 23, 2010 |
| Last updated in NPPES | Mar 28, 2019 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Critical Care Medicine Primary | 207RC0200X | 258330 | NY |
| Internal Medicine, Pulmonary Disease | 207RP1001X | 258330 | NY |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Pulmonary Disease (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 86 |
|---|---|
| Services billed | 1,131 across 18 procedure codes |
| Paid by Medicare | $44,957 |
Part D prescriptions in 2024
| Prescriptions (claims) | 12,059 · 13,184 30-day fills |
|---|---|
| Patients | 843 |
| Total drug cost | $4,767,623 |
| Generic share | 48% of claims |
Education and affiliations
| Medical school | New York Medical College |
|---|---|
| Graduation year | 2007 |
| Medicare specialty | Pulmonary Disease |
| Secondary specialties | Critical Care (Intensivists), Internal Medicine |
Industry payments (Open Payments)
- 2025$4,154 · 255 payments from 11 companies
- 2024$4,334 · 221 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,748 | 122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $714.31 | 33 |
| Glaxosmithkline, LLC. | $701.61 | 43 |
| Philips North America LLC | $269.64 | 11 |
| Insmed, Inc. | $179.71 | 14 |
What the 2025 payments were for
- Food and Beverage$4,154 · 255 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other critical care physicians in New York
- 1104042886
- 1265575138
- 1275056459
- 1396001061
- 1467870931
- 1487917837
- 1538155064
- 1598021255
- 1659304509
- 1740690882
- 1841441714
- 1558003517
All 145 critical care physicians in New York · All critical care physicians in New York